Discover trends, market shifts, and competitive outlooks for the calcium gluconate industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Calcium Gluconate Market Expected to Grow Between 2025 And 2029?

In the past few years, the calcium gluconate market has seen significant expansion. Its value is set to increase from $110.12 billion in 2024 to $119.38 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The increase during the historical period can be credited to factors such as economic advancement and industrialization, the heightened use of calcium gluconate in functional foods, the rising demand for pharmaceuticals and dietary supplements, growing cognizance of calcium deficiency, and supportive regulations for food additives.

The market size for calcium gluconate is set to experience robust expansion in the coming years, reaching a value of $162.69 billion in 2029, with projected Compound Annual Growth Rate (CAGR) of 8.0%. This growth during the projected period can be linked to a variety of factors such as a rising elderly population and increased health awareness, the enlargement of the food and drink sector, the use of digital marketing and e-commerce for product marketing, shifting preference towards organic and natural products, burgeoning markets, and increasing urbanization. The anticipated trends within this period include healthcare research and development with an emphasis on sustainable sourcing and production, use of calcium gluconate in medicine, bespoke formulation for specialized health requirements, and advancements in technology in production processes.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16005&type=smp

Which Primay Drivers Are Accelerating Growth in the Calcium Gluconate Market?

The surge in osteoporosis incidence is anticipated to fuel the calcium gluconate market’s expansion. Osteoporosis, a medical disorder characterized by bone fragility due to loss of bone density and strength, is often linked to sedentary lifestyles, insufficient calcium consumption, hormonal shifts, and certain diseases or medications. Calcium gluconate is a crucial component of osteoporosis treatment, bolstering dietary calcium intake and promoting bone health. For instance, as per December 2023 data from the Australian Institute of Health and Welfare (AIHW), an Australian government entity, osteoporosis accounted for 2,366 fatalities, a death rate of 6.5 per 100,000 individuals, and represented 1.4% of all deaths in 2022. Moreover, 9,500 hospital admissions were chiefly attributed to osteoporosis in 2021-22, equating to 89 hospitalizations per 100,000 population for people aged 45 and above. Consequently, the rising osteoporosis incidence is propelling the growth of the calcium gluconate market. Growth in the calcium gluconate market is forecasted to be driven by the escalating healthcare expenditure. ‘Healthcare’ refers to a systematic set-up of medical services, amenities, professionals, and resources aiming to foster, preserve, and recuperate the physical and mental health of individuals and communities. The growth of healthcare spending is attributed to factors such as aging demographics, rise in chronic disease prevalence, advancements in medical technology, and an increased demand for quality healthcare services. In the healthcare sector, calcium gluconate is typically employed to address conditions triggered by low calcium levels like hypocalcemia, cardiac arrest, and certain toxicities. For instance, financial projections from the Office for Budget Responsibility (OBR) and the Treasury, a UK-based non-ministerial government department, propose that the UK’s health spending plan will escalate to £192 billion ($244.43 billion) in 2024/25 from £182 billion ($231.70 billion) in 2022/23. Therefore, the rise in healthcare expenditure is stimulating the calcium gluconate market’s growth.

Which Primary Segments of the Calcium Gluconate Market Are Driving Growth and Industry Transformations?

The calcium gluconate market covered in this report is segmented –

1) By Form: Liquid, Tablet, Powder, Gel

2) By Grade: Pharmaceutical Grade, Food Grade

3) By Application: Food And Beverage Manufacturers, Pharmaceutical, Nutraceutical, Cosmetic And Personal Care, Other Applications

4) By End Use: Emulsifier, Bulking Agent, Thickening Agent

Subsegments:

1) By Liquid: Injectable Solution, Oral Liquid, IV Infusion

2) By Tablet: Standard Tablets, Effervescent Tablets

3) By Powder: Oral Powder, Injectable Powder

4) By Gel: Topical Gel, Transdermal Gel

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16005&type=smp

Which Regions Are Key Players in the Growth of the Calcium Gluconate Market?

Europe was the largest region in the calcium gluconate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcium gluconate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Calcium Gluconate Industry Evolution?

Leading businesses in the calcium gluconate market are putting their resources into the development and regulatory approval of calcium gluconate drugs. These steps aim to improve the available treatments for conditions related to calcium deficiencies. The process from discovering a drug to getting its approval for market distribution is intricate and multi-faceted, including stages like preclinical testing and clinical trials. For example, in September 2023, Amneal Pharmaceuticals Inc., a US-based generics and specialty pharmaceutical company listed publicly, was given approval for abbreviated new drug application (ANDA) by the U.S. Food and Drug Administration (FDA) to produce calcium gluconate in sodium chloride injection. The FDA approved this product and granted it the Competitive Generic Therapy (CGT) label, along with a 180-day exclusivity period. The approved substance comes in two variants: 1000 mg/50 mL and 2000 mg/100 mL. Calcium gluconate in sodium chloride injection, presented in a small-volume parenteral bag, is used for the treatment of acute symptomatic hypocalcemia in both children and adults.

View the full report here:

https://www.thebusinessresearchcompany.com/report/calcium-gluconate-global-market-report

What Parameters Are Used to Define the Calcium Gluconate Market?

Calcium gluconate is a mineral supplement used to treat or prevent calcium deficiencies and to manage conditions such as hypocalcemia, osteoporosis, and certain muscle spasms. It works by replenishing calcium stores in the body, aiding in bone strength and muscle function. This is often administered intravenously or orally to restore normal calcium levels in the blood.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16005

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model